top of page

THERALYZE

Screenshot 2024-08-14 at 10.09.02-02.png

AI-Driven Case Intake

Before and After TheraLyze.jpg

Eliminate Manual Data Entry and Reduce Quality Control Time.

Screenshot 2024-08-14 at 14.13.20-2.png

Save costs, time, enhance speed and empower Case Processors

Screenshot 2024-08-14 at 10.16.43-2.png

What we do

TheraLyze.ai revolutionizes case intake by eliminating manual data entry and significantly reducing the total time spent on processing and submitting cases to regulators.

Use Case

CROs and pharmaceutical companies use TheraLyze.ai to automate case intake, extract key data, generate E2B R3 files, and integrate seamlessly with pharmacovigilance databases.

How it works

  1. Data Conversion
    Transforms unstructured and structured data (e.g., PDFs, emails, social media posts, forms, audio files) into structured formats.  
  2. E2B R3 Generation
    Produces E2B R3 files compliant with regulatory standards.  ​
  3. Database Integration: Seamlessly integrates generated files with any pharmacovigilance database.  
  4. ​Compliance Assurance: Operates with full GDPR compliance for data security and privacy.  
HowItworks.png

REACH OUT

Let’s Talk - Contact Us

Get ahead of AI today

Profile.jpeg

Founder, CEO

Sunil Kulkarni, founder & CEO of TheraLyze.ai, leverages deep expertise in technology and life sciences. Formerly a leader at Veeva Systems, he specializes in AI, machine learning, and scalable solutions to streamline workflows, boost quality, and ensure compliance.
bottom of page